March 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster ~2 min.AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....
March 15, 2025AstraZeneca's Experimental Blood Pressure Drug Shows Promising Results, Outperforms Broader Market ~1 min.AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....
March 14, 2025AstraZeneca's Imfinzi success a step towards revolutionizing cancer treatment ~2 min.AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....
February 28, 2025AstraZeneca PLC AZN: A Global Pharmaceutical Giant with Promising Growth Potential ~2 min.AstraZeneca PLC (AZN) is a renowned multinational pharmaceutical company with a strong presence in the global market....
February 26, 2025AstraZeneca PLC's Groundbreaking Research Leads to Exciting Discoveries in the Field of Medicine ~2 min.AstraZeneca PLC, a leading pharmaceutical company, has made significant advancements in the field of medicine through its groundbreaking research....
January 2, 2025AstraZeneca PLC Announces Breakthrough in Cancer Treatment Research ~2 min.AstraZeneca PLC, a leading global pharmaceutical company, has reported a significant breakthrough in its cancer treatment research....
January 1, 2025New breakthrough in medical research announced by AstraZeneca PLC AZN ~2 min.Leading pharmaceutical company AstraZeneca PLC AZN has made a groundbreaking discovery in the field of medical research....
January 2, 2025AstraZeneca PLC Develops Breakthrough Treatment for Rare Disease ~2 min.AstraZeneca PLC, a leading pharmaceutical company, has announced a major breakthrough in the development of a treatment for a rare disease....
February 15, 2025AstraZeneca PLC AZN: Pioneering New Breakthrough in Cancer Treatment ~2 min.AstraZeneca PLC, a global biopharmaceutical company, has recently announced a major breakthrough in cancer treatment....
October 31, 2024AstraZeneca PLC Collaborates with Monopar Therapeutics on Rare Disease Treatment ~1 min.Monopar Therapeutics, a biopharmaceutical company specializing in rare disease treatments, has announced a groundbreaking partnership with AstraZeneca PLC....
